http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6132769-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_577821cf81fda3e1088e6ed08bcd136b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 1996-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_323967d3cd253ec130408cd64b47b270
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8d4bb662bd9ad9d67ce35abe2876d0c
publicationDate 2000-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6132769-A
titleOfInvention Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
abstract The present invention relates to pharmaceutical matrix pellet formulations providing an adequate drug release profile. The matrix of said pellets is formed from: (a) a hydrophilic compound selected among the group consisting of starch, a starch derivative and mixture thereof, and (b) a hydrophobic compound selected among the group consisting of wax, micro-crystalline wax and mixture thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7931778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014107146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969369-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007224269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010255090-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004185111-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9687451-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004185093-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10039717-B2
priorityDate 1995-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4235870-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4574080-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2081092-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4963359-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2204792-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0540460-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3146167-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4102806-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127538318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22770772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127963844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135781492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226541757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749

Total number of triples: 58.